Stock Analiz

Ocular Therapeutix, Inc. (OCUL) stock forecast and price target

Price $6.21 · data as of November 13, 2026

12-month price target

Average target$25.73
Upside / downside+314.3%
Analysts11
ConsensusStrong buy
Low $14.00Average $25.73High $34.00

Gold marker: average target · white marker: today’s price ($6.21)

Analyst ratings

Strong buy 4Buy 8Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.53−7.7%$51M
Next fiscal year
ends December 31, 2027
$-1.59−4.2%$91M
Quarter after
ends March 31, 2027
$-0.38+4.6%$12M

Consensus of the analysts covering Ocular Therapeutix, updated daily. In the last 30 days 3 estimates were raised and 0 lowered.

Frequently asked questions

What is the Ocular Therapeutix stock price target?

The average 12-month target from 11 analysts is $25.73, 314.3% above the current price of $6.21 Targets range from $14.00 to $34.00.

Is Ocular Therapeutix a buy according to analysts?

The consensus rating is “Strong buy” (4 strong buy, 8 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Ocular Therapeutix expected to earn?

Analysts expect EPS of $-1.53 for the fiscal year ending December 31, 2026 and $-1.59 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.